Tupelo Data Room

pharmacy for Sale in Texas

Explore pharmacy for sale in Texas. Compare opportunities and connect with sellers.

Pharmacies

Licensed Retail Pharmacy Platform, 503a Sterile Compounding Equipment

Pearland, Brazoria County, TX, US

Confidential opportunity to acquire or strategically partner with an established licensed retail pharmacy platform located in the Pearland / Greater Houston, Texas market. The business operates from an existing pharmacy facility and combines traditional prescription dispensing with third-party payer/PBM access, delivery and digital capabilities, a two-pharmacist team, and sterile/non-sterile compounding equipment and infrastructure available. The company has acquired sterile/nonsterile compounding equipment and infrastructure (currently in storage and is positioned for implementation. The pharmacy has demonstrated the ability to process prescriptions across a broad payer base, with historical activity involving major commercial and government channels. Current/historical documentation includes CVS Caremark-related activity, Medicare Part D, Humana, Aetna, Optum / Prescription Solutions and other managed-care payers. The operating platform provides a potential strategic buyer with an existing licensed pharmacy, personnel, dispensing workflow and reimbursement infrastructure rather than requiring a greenfield build. Company reporting for 2025 reflects approximately $1.98 million of prescription revenue, approximately $1.38 million of prescription-level gross profit and approximately 2,221 prescriptions, representing a reported Rx-level gross margin of approximately 69.9%. The supplied 2026 transaction file through the available period contains 880 fill transactions, approximately $486,000 of revenue, approximately $172,000 of acquisition cost and approximately $314,000 of reported transaction-level gross profit. Revenue has declined from prior peak periods, creating a different type of strategic opportunity: the facility, pharmacy licenses, payer relationships, pharmacist staffing and available compounding infrastructure may have significant value to an operator capable of introducing immediate prescription or fulfillment volume. Ownership is willing to entertain significant and meaningful strategic arrangements with qualified parties that can bring business to the platform, including fulfillment agreements, joint ventures, strategic investments and acquisition structures involving continued seller equity participation. The pharmacy also has sterile and non-sterile compounding equipment available and is positioned for further development of personalized medicine and compounding services, subject to all applicable licensing, certification, regulatory and operational requirements. This creates potential upside for a qualified operator seeking an existing pharmacy base from which to build higher-value prescription, provider, telehealth, wellness or compounding programs. · Licensed Operating Platform – Existing Texas Class A Retail Pharmacy License and DEA registration, with an established Pearland pharmacy facility. · Existing PBM / Payer Access – Contracted across various commercial, Medicare, Medicaid and managed-care channels, including CVS Caremark related activity. · Two-Pharmacist Team – Existing pharmacist staffing (1 Pharmacist, 1 Pharmacist Owner, 2 Techs) supports continuity and provides an operating base for incremental prescription volume. · Attractive Historical Rx-Level Economics – 2025 pharmacy-system reporting reflects approximately $1.98M of Rx revenue and approximately $1.38M of Rx-level gross profit. 2026 Revenue has seen a significant decline, at $486k Gross Revenue through Sept 2026. · Strategic Fulfillment Capacity – Existing pharmacy infrastructure may allow a strategic buyer or partner to introduce prescription volume without creating a pharmacy platform from the ground up. · Flexible Transaction Structures – Seller is open to meaningful fulfillment, JV, strategic investment and equity-roll opportunities with qualified counterparties capable of bringing immediate business.

$199,918Asking Price
$486,000Revenue
-Cash Flow
Medical Practices
Pharmacies

$7.6m EBITDA Specialty Pharmacy (Confidential)

Austin, Travis County, TX, US

Multi-site specialty pharmacy platform licensed in 14 states with integrated secondary fulfillment. The Company enjoys strong & stable financial performance, with consistent revenue and high operating margins. The Company’s experienced management team has proven their operational expertise, and is willing to remain onboard. Each department has been built out to support the operation, offering complete coverage from onboarding and business development teams, through fulfillment, compliance, customer support and billing. Services include prescriptions, compounding, medication therapy management, home delivery, and clinical support. Multiple locations, with centralized fulfillment capabilities for other states. Investment Highlights Attractive Unit Economics: High gross margins and strong EBITDA conversion rates. Diversified Revenue Streams: The Company is a leader in and maintains expertise in workflow, and processing for various types of patients, related to payors known for high reimbursements. Diverse Referral Base: The Company receives referrals from 100s of Clinics in the region. No one referral source accounts for a large percentage of Regulatory & Operational Moat: Multi-state licensure and HIPAA-compliant fulfillment operations. Technology-Enabled Operations: Automated refill, synchronization, and next-day delivery systems. Experienced Leadership: Management Team alone possesses over 80+ years combined pharmacy and healthcare management experience. Full Revenue Cycle: Well established and currently at full revenue cycle. Proven Scalability: Turnkey platform ready for add-on acquisitions and new market expansion. CONFIDENTIAL SALE. PROOF OF PORTFOLIO OR RELATED HEALTHCARE INDUSTRY / INVESTMENT BACKGROUND REQUIRED PRIOR TO RELEASE OF CONFIDENTIAL INFORMATION.

-Asking Price
$11,238,357Revenue
$7,577,566Cash Flow
Independent Pharmacy with Significant Growth Potential photo
Pharmacies

Independent Pharmacy with Significant Growth Potential

Blanco County, TX, US

Confidential opportunity to acquire an established independent pharmacy serving a solid, growing Texas Hill Country market. The business is currently operating with a simple model focused primarily on prescription filling, creating substantial upside for a buyer with the vision and operational experience to expand services and unlock additional revenue streams. This is an excellent opportunity for a regional group or strategic acquirer seeking to add a community-based location with meaningful growth potential. It is equally well suited for a younger pharmacist, including one looking to build a long-term future for themselves and their family in a wholesome, down-home Texas small-town community with strong values and an appealing quality of life. At present, the pharmacy’s limited service mix leaves clear room for expansion through value-added offerings such as immunizations, medication synchronization, adherence packaging, delivery, compounding, provider outreach, front-end merchandising, and other patient-centered services. A buyer who can execute on these opportunities may be able to significantly enhance both revenue and overall enterprise value. The pharmacy benefits from an established presence, local customer relationships, and a community setting where personal service and healthcare access matter. Seller is seeking a smooth transition and will consider qualified buyers who appreciate the long-term potential of the business and the market it serves. Additional information available to qualified buyers upon execution of a confidentiality agreement.

$276,421Asking Price
$1,400,000Revenue
$120,000Cash Flow
Turnkey Texas Retail & Wholesale Pharmacy – Fully Licensed, Contracted photo
Medical Practices
Pharmacies

Turnkey Texas Retail & Wholesale Pharmacy – Fully Licensed, Contracted

Grayson County, TX, US

An Acquitrust Exclusive. Step into a fully rehabilitated, highly optimized business foundation where all the heavy lifting has already been done. This is a rare, exclusive opportunity to acquire an established pharmacy platform that is fully licensed, contracted, and primed for massive scaling. Completely overhauled and modernized by the current ownership group, this operation offers a buyer the ultimate "plug-and-play" infrastructure with highly favorable overhead and instant revenue potential. Priced for an immediate sale, this opportunity will not last long. Key Highlights: Location: The pharmacy is located in Texas. All Major PBMs Secured: Fully active and re-established contracts with all major PBMs and insurance providers. Dual Licensing Included: Comes with both active retail pharmacy and wholesale licensing, offering multiple lucrative revenue streams. Unbeatable Low Overhead: Highly favorable lease terms with a remarkably low rent of just $1,850 per month, maximizing your profit margins from day one. Built-In Immediate Revenue: The current ownership is open to maintaining a business relationship post-closing and is willing to act as your initial wholesale customer, providing immediate cash flow and continuity! Premium Infrastructure: Existing systems, operational history, and active relationships with some of the industry’s largest primary vendors are already in place. Powerful Purchasing History: Historically, substantial inventory purchasing flowed through this operation, giving a new owner highly beneficial, established buying power. Untapped Compounding Upside: Features a dedicated, built-out non-sterile compounding room—a massive opportunity to instantly expand into high-margin customized compounding services. Why This Opportunity is Unique You are not starting from scratch. The current owners took on the painstaking work of restoring compliance, rebuilding top-tier vendor relationships, and streamlining the retail footprint. You are stepping into a clean, flawlessly structured entity with a lean operational model that is practically begging to be scaled. Whether your business model focuses on expanding retail volume, leveraging the compounding room, or heavily scaling the wholesale division, this platform offers the ultimate flexibility to grow in any direction. This is a highly confidential, exclusive sale. The foundation is built, the contracts are signed, and the business is ready for its next visionary owner. At Acquitrust Advisors, we are not just traditional business brokers. We are experienced business owners and strategic advisors who understand the true value of a well-built enterprise. We meticulously curate premium, confidential acquisition opportunities, ensuring perfect alignment and success for both buyers and sellers. NDA and proof of funds required.

$300,000Asking Price
$1Revenue
$1Cash Flow

What to know about pharmacy acquisitions

GW

By George Wellmer

Cofounder & CEO

Key diligence, valuation, financing, and transition considerations for buyers evaluating pharmacy acquisitions.

Sale prices have risen as larger pharmacies enter the market

Median pharmacy sale prices increased from $262,500 in 2021 to $600,000 in 2025, while median revenue grew from $675,000 to $2.5 million over the same period. This suggests that higher sale prices are being driven primarily by larger pharmacies entering the market rather than by buyers paying higher valuation multiples for similar businesses. For individual buyers, this distinction matters. The median transaction may not be representative of a small independent pharmacy in a residential neighborhood. More meaningful comparisons come from pharmacies with similar revenue, prescription volume, payer mix, and operating characteristics.

SDE margin has compressed dramatically

Discretionary earnings as a percentage of revenue dropped to 7.3% in 2025, down from 18.4% in 2024. The compression reflects structural PBM reimbursement pressure that has reduced the spread on dispensed prescriptions, plus rising operating costs that haven't been offset by reimbursement increases. Buyers should not assume historical margins continue forward. A pharmacy that ran 15% SDE margins in 2022 may run 7-8% today on the same revenue. Underwrite to current reimbursement environment, not historical performance.

Multiple valuation approaches give different answers

Common rules of thumb: 18-22% of gross sales; $200-$400 per active prescription. A pharmacy doing $2M in revenue with $200K in SDE might value between $400K (revenue multiple) and $700K (SDE multiple). The right number depends on the pharmacy's quality factors: payer mix (more cash and commercial, less Medicare/Medicaid is better), niche services (compounding, long-term care, 340B), script-file age (fresh prescriptions and active patients vs old, dormant records), and growth trajectory. Buyers should triangulate across methods.

Niche pharmacies command meaningful premiums

Compounding pharmacies, long-term care pharmacies, 340B-eligible pharmacies, and pharmacies with strong clinical service programs (vaccinations, MTM, diabetes management) trade at premiums over generic retail pharmacies. Niche pharmacies generate higher gross margins (compounding can run 40-60%+ vs 18-22% for typical retail) and have less PBM exposure on specialty work. A buyer evaluating a pharmacy should identify any niche capabilities, understand the revenue and margin contribution, and value those separately from the underlying retail dispensing business.

Inventory is meaningful and needs separate valuation

A typical pharmacy carries $150,000-$500,000 in inventory at any time. Pharmacy inventory turns 8-12 times per year. Inventory is usually a separate negotiation from the business value, paid at landed cost or at agreed adjustments. Controlled substances inventory requires specific transfer protocols (DEA Form 222 and similar). Expiring inventory is the buyer's risk if not separately negotiated. Business buyers should do an inventory walk-through with the seller and document what's near expiration and what's slow-moving.

Real estate and lease economics shape downstream options

Many pharmacies operate from leased space; some include owned real estate. Lease economics matter enormously as pharmacies are foot-traffic businesses, and a pharmacy with a strong lease in a high-visibility location is worth more than the same business in a side-street location with a short remaining lease. Where the seller owns the real estate, buyers should evaluate whether to acquire the real estate (locking in occupancy cost) or lease it back (preserving capital for working capital and acquisition financing). The two paths have meaningfully different total economics.

Frequently Asked Questions

Answers to common buyer questions for this market.

Median pharmacy sale prices reached $600,000 in 2025. Multiples typically run 2.5x-3.5x seller's discretionary earnings or 18-22% of annual gross sales. A pharmacy with $2M revenue and $200K SDE typically lists between $500K and $800K, with niche pharmacies (compounding, LTC, 340B) commanding meaningful premiums.